Cryoprecipitate use in the PROMMTT study

Journal of Trauma and Acute Care Surgery

Volumn 75, Issue 1 SUPPL1, 2013, Pages

  Holcomb, John B ^a   Fox, Erin E ^b   Zhang, Xuan ^b   White, Nathan ^d   Wade, Charles E ^a   Cotton, Bryan A ^a   Del Junco, Deborah J ^a   Bulger, Eileen M ^e   Cohen, Mitchell J ^f   Schreiber, Martin A ^g   Myers, John G ^h   Brasel, Karen J ^h   Phelan, Herb A ^c,d   Alarcon, Louis H ⁱ   Muskat, Peter ^j   Rahbar, Mohammad H ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b Center for Clinical and Translational Sciences   (United States)

^c University of Texas Health Science Center   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^h MEDICAL COLLEGE OF WISCONSIN   (United States)

ⁱ UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF CINCINNATI   (United States)

more..

Author keywords

Bleeding; Cryoprecipitate; Fibrinogen; Injury; PROMMTT

Indexed keywords

FIBRINOGEN; HEMOGLOBIN;

ADULT; BLOOD PH; CONFERENCE PAPER; CONTROLLED STUDY; CRYOPRECIPITATE; FEMALE; GLASGOW COMA SCALE; HUMAN; INJURY SCALE; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SURVIVAL; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD TRANSFUSION; CHI-SQUARE DISTRIBUTION; FACTOR VIII; FEMALE; FIBRINOGEN; HEMORRHAGE; HOSPITAL MORTALITY; HUMANS; INJURY SEVERITY SCORE; INTERVENTION STUDIES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RESUSCITATION; RISK FACTORS; STATISTICS, NONPARAMETRIC; TIME FACTORS; TRAUMA CENTERS; TREATMENT OUTCOME; UNITED STATES; WOUNDS AND INJURIES;

EID: 84880422187     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e31828fa3ed     Document Type: Conference Paper

References (36)

1. Evans JA, van Wessem KJ, McDougall D, Lee KA, Lyons T, Balogh ZJ. Epidemiology of traumatic deaths: comprehensive population-based assessment. World J Surg. 2010;34:158-163.
2. Borgman MA, Spinella PC, Perkins JG, GrathwohlKW, Repine T, Beekley AC, Sebesta J, Jenkins D, Wade CE, Holcomb JB. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma. 2007;63:805-813.
3. Holcomb JB, Jenkins D, Rhee P, Johannigman J, Mahoney P, Mehta S, Cox ED, Gehrke MJ, Beilman GJ, Schreiber M, et al. Damage control resuscitation: directly addressing the early coagulopathy of trauma. J Trauma. 2007;62:307-310.
4. Holcomb JB, Wade CE, Michalek JE, Chisholm GB, Zarzabal LA, Schreiber MA, Gonzalez EA, Pomper GJ, Perkins JG, Spinella PC, et al. Increased plasma and platelet to red blood cell ratios improves outcome in 466 massively transfused civilian trauma patients. Ann Surg. 2008; 248:447-458.
5. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma. 2003;54:1127-1130.
6. Holcomb JB, del Junco DJ, Fox EE, Wade CE, Cohen MJ, Schreiber MA, Alarcon LH, Bai Y, Brasel KJ, Bulger EM, et al. The PRospective, Observational, Multicenter, Major Trauma Transfusion (PROMMTT) Study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg. 2013;148:127-136.
7. Maegele M, Lefering R, Paffrath T, Tjardes T, Simanski C, Bouillon B. Red-blood-cell to plasma ratios transfused during massive transfusion are associated with mortality in severe multiple injury: a retrospective analysis from the Trauma Registry of the Deutsche Gesellschaft fur Unfallchirurgie. Vox Sang. 2008;95:112-119.
8. Shaz BH, Dente CJ, Nicholas J, MacLeod JB, Young AN, Easley K, Ling Q, Harris RS, Hillyer CD. Increased number of coagulation products in relationship to red blood cell products transfused improves mortality in trauma patients. Transfusion. 2010;50:493-500.
9. Duchesne JC, Islam TM, Stuke L, Timmer JR, Barbeau JM, Marr AB, Hunt JP, Dellavolpe JD, Wahl G, Greiffenstein P, et al. Hemostatic resuscitation during surgery improves survival in patients with traumaticinduced coagulopathy. J Trauma. 2009;67:33-37.
10. Stinger HK, Spinella PC, Perkins JG, Grathwohl KW, Salinas J, Martini WZ, Hess JR, Dubick MA, Simon CD, Beekley AC, et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma. 2008;64:S79-S85.
11. Kashuk JL, Moore EE, Johnson JL, Haenel J, Wilson M, Moore JB, Cothren CC, Biffl WL, Banerjee A, Sauaia A. Postinjury life threatening coagulopathy: is 1:1 fresh frozen plasma:packed red blood cells the answer? J Trauma. 2008;65:261Y270.
12. Cotton BA, Reddy N, Hatch QM, Lefebvre E, Wade CE, Kozar RA, Gill BS, Albarado R, McNutt MK, Holcomb JB. Damage control resuscitation is associated with a reduction in resuscitation volumes and improvement in survival in 390 damage control laparotomy patients. Ann Surg. 2011;254:598-605.
13. U.S. Army Institute of Surgical Research. Joint theater trauma system clinical practice guideline: damage control resuscitation at level IIb/III treatment facilities. Available at: http://www.usaisr.amedd.army.mil/assets/ cpgs/Damage-Control-Resuscitation-11-Oct%202012.pdf. Accessed October 22, 2012.
14. Duke MD, Guidry C, Guice J, Stuke L, Marr AB, Hunt JP, Meade P, McSwain NE, Jr., Duchesne JC. Restrictive fluid resuscitation in combination with damage control resuscitation: time for adaptation. J Trauma Acute Care Surg. 2012;73:674-678.
15. AABB. Circular of information for the use of human blood and blood components. Available at: http://www.aabb.org/resources/bct/Documents/coi0809r. pdf. Accessed October 22, 2012.
16. Ciavarella D, Reed RL, Counts RB, Baron L, Pavlin E, Heimbach DM, Carrico CJ. Clotting factor levels and the risk of diffuse microvascular bleeding in the massively transfused patient. Br J Haematol. 1987; 67:365-368.
17. Nascimento B, Rizoli S, Rubenfeld G, Fukushima R, Ahmed N, Nathens A, Lin Y, Callum J. Cryoprecipitate transfusion: assessing appropriateness and dosing in trauma. Transfus Med. 2011;21:394-401.
18. Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez- Mondejar E, Hunt BJ, Komadina R, Nardi G, Neugebauer E, et al. Management of bleeding following major trauma: an updated European guideline. Crit Care. 2010;14:R52.
19. Solomon C, Pichlmaier U, Schoechl H, Hagl C, Raymondos K, Scheinichen D, Koppert W, Rahe-Meyer N. Recovery of fibrinogen after administration of fibrinogen concentrate to patients with severe bleeding after cardiopulmonary bypass surgery. Br J Anaesth. 2010;104:555-562.
20. Ranucci M, Solomon C. Supplementation of fibrinogen in acquired bleeding disorders: experience, evidence, guidelines, and licences. Br J Anaesth. 2012;109:135-137.
21. Fenger-Eriksen C, Moore GW, Rangarajan S, Ingerslev J, Sorensen B. Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders. Transfusion. 2010;50: 2571-2576.
22. Tinegate H, Allard S, Grant-Casey J, Hennem S, Kilner M, Rowley M, Seeney F, Stanworth S. Cryoprecipitate for transfusion: which patients receive it and why? A study of patterns of use across three regions in England. Transfus Med. 2012;22:356-361.
23. Sorensen B, Tang M, Larsen OH, Laursen PN, Fenger-Eriksen C, Rea CJ. The role of fibrinogen: a new paradigm in the treatment of coagulopathic bleeding. Thromb Res. 2011;128(suppl 1):S13-S16.
24. Rourke C, Curry N, Khan S, Taylor R, Raza I, Davenport R, Stanworth S, Brohi K. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost. 2012;10:1342-1351.
25. Schochl H, Nienaber U, Maegele M, Hochleitner G, Primavesi F, Steitz B, Arndt C, Hanke A, Voelckel W, Solomon C. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care. 2011; 15:R83.
26. Fenger-Eriksen C, Jensen TM, Kristensen BS, Jensen KM, Tonnesen E, Ingerslev J, Sorensen B. Fibrinogen substitution improves whole blood clot firmness after dilution with hydroxyethyl starch in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost. 2009;7:795-802.
27. Karlsson M, Ternstrom L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost. 2009;102:137-144.
28. Fries D. Fibrinogen concentrate (FGTW) in trauma patients, presumed to bleed. Available at: http://clinicaltrials.gov/ct2/show/NCT01475344. Accessed October 22, 2012.
29. Rahbar MH, Fox EE, del Junco DJ, Cotton BA, Podbielski JM, Matijevic N, Cohen MJ, Schreiber MA, Zhang J, Mirhaji P, et al. Coordination and management of multicenter clinical studies in trauma: experience from the PRospective Observational Multicenter Major Trauma Transfusion (PROMMTT) Study. Resuscitation. 2012;83:459-464.
30. Bursac Z, Gauss CH, Williams DK, Hosmer DW. Purposeful selection of variables in logistic regression. Source Code Biol Med. 2008;3:17.
31. Hosmer DW, Lemeshow S. Applied Survival Analysis: Regression Modeling of Time to Event Data. New York, NY: John Wiley & Sons; 1999:159-187.
32. Holcomb JB, Minei KM, Scerbo ML, Radwan ZA, Wade CE, Kozar RA, Gill BS, Albarado R, McNutt MK, Khan S, et al. Admission rapid thrombelastography can replace conventional coagulation tests in the emergency department: experience with 1974 consecutive trauma patients. Ann Surg. 2012;256:476-486.
33. Martini WZ, Holcomb JB. Acidosis and coagulopathy: the differential effects on fibrinogen synthesis and breakdown in pigs. Ann Surg. 2007;246:831-835.
34. Martini WZ, Chung KK, Dubick MA, Blackbourne LH. Daily profiles of fibrinogen metabolism for 5 days following hemorrhage and lactated ringer's resuscitation in pigs. Shock. 2012;37:605-610.
35. Fries D, Haas T, Klingler A, Streif W, Klima G, Martini J, Wagner-Berger H, Innerhofer P. Efficacy of fibrinogen and prothrombin complex concentrate used to reverse dilutional coagulopathyVa porcine model. Br J Anaesth. 2006;97:460-467.
36. Sorensen B, Fries D. Emerging treatment strategies for trauma-induced coagulopathy. Br J Surg. 2012;99(suppl 1):40-50.